Skip to content

Clinical trials

Completed Phase 2 Leiomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Phase: Phase 2 Status: Completed Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20033
20041
20054
20064
20073
20083
20093
20101
20111
20122
20141
20153
20162
20171
20193
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Memorial Sloan Kettering Cancer Center5
European Organisation for Research and Treatment of Cancer - EORTC4
Dana-Farber Cancer Institute2
Institut Bergonié2
Massachusetts General Hospital2
Sarcoma Alliance for Research through Collaboration2
UNICANCER2
AGO Study Group1
Alexander Z. Wei, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma43
Sarcoma29
Liposarcoma21
Sarcoma, Synovial19
Histiocytoma, Malignant Fibrous17
Hemangiosarcoma15
Fibrosarcoma14
Neurofibrosarcoma14
Rhabdomyosarcoma11
Osteosarcoma7

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.